Recruiting Heart Attack Studies in Lake Charles
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of t...
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE)....
About Heart Attack Clinical Trials in Lake Charles
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Lake Charles, LOUISIANA. These studies are seeking a combined 740 participants. Research is being sponsored by Novartis Pharmaceuticals, Zenas BioPharma (USA), LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Lake Charles — FAQ
Are there heart attack clinical trials in Lake Charles?
Yes, there are 2 heart attack clinical trials currently recruiting in Lake Charles, LOUISIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lake Charles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lake Charles research site will contact you about next steps.
Are clinical trials in Lake Charles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lake Charles studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Lake Charles are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov